PROCESS FOR MAKING DIHYDROPYRIDINE

1,4-Dihydropyridine derivatives of the formula:-and their pharmaceutically acceptable acid addition salts; whereR is aryl or heteroaryl;R1 and R2 are each independently C1-C4 alkyl or 2-methoxyethyl;Y is -(CH2)2-, -(CH2)3-, -CH2CH(CH3)- or -CH2C(CH3)2-;R3 is hydrogen or a group selected from:-where...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: COMPBELL S.F, STUBBS J.K, CROSS P.E
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator COMPBELL S.F
STUBBS J.K
CROSS P.E
description 1,4-Dihydropyridine derivatives of the formula:-and their pharmaceutically acceptable acid addition salts; whereR is aryl or heteroaryl;R1 and R2 are each independently C1-C4 alkyl or 2-methoxyethyl;Y is -(CH2)2-, -(CH2)3-, -CH2CH(CH3)- or -CH2C(CH3)2-;R3 is hydrogen or a group selected from:-where R4 is H, C1-C4 alkyl, C3-C6 cycloalkyl, -COO(C1-C4 alkyl), -CH2COO(C1-C4 alkyl), aryl, -S02.aryl, or heteroaryl, and X is 0 or S;where R5 is 1-pyrrolidinyl, -NH2, -NH(C1-C4 alkyl), -N/C1-C4 alkyl)2, or -NH(CH2)2N(C1-C4 alkyl)2;where R6 is C1-C4 alkyl or aryl;where R7 is -CONH(C1-C4 alkyl) or -COO(C1-C4 alkyl);where R8 is -CN, -SO2(C1-C4 alkyl) or -SO2 aryl;(h) -CH2CO.R9 where R9 is -NH2, -NH(C1-C4 alkyl), -NH.aryl or C1-C4 alkoxy;(i) -SO2.R10 where R10 is -NH2, -N(C1-C4 alkyl)2 or C1-C4 alkyl; and(j) -CO.R" where R" is H, halomethyl, -COO(C1-C4 alkyl), -CH2O(C1-C4 alkyl), -CH2CO(C1-C4 alkyl), C1-C4 alkyl, C1-C4 alkoxy, aryl, heteroaryl, morpholino or 5-oxo-pyrrolidin-2-yl.The compounds have utility as anti-ischaemic and antihypertensive agents.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_YU43659BB</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>YU43659BB</sourcerecordid><originalsourceid>FETCH-epo_espacenet_YU43659BB3</originalsourceid><addsrcrecordid>eNrjZFAKCPJ3dg0OVnDzD1LwdfT29HNXcPH0iHQJ8g-IDPJ08fRz5WFgTUvMKU7lhdLcDHJuriHOHrqpBfnxqcUFicmpeakl8ZGhJsZmppZOTsYEFQAAjsAhzQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PROCESS FOR MAKING DIHYDROPYRIDINE</title><source>esp@cenet</source><creator>COMPBELL S.F ; STUBBS J.K ; CROSS P.E</creator><creatorcontrib>COMPBELL S.F ; STUBBS J.K ; CROSS P.E</creatorcontrib><description>1,4-Dihydropyridine derivatives of the formula:-and their pharmaceutically acceptable acid addition salts; whereR is aryl or heteroaryl;R1 and R2 are each independently C1-C4 alkyl or 2-methoxyethyl;Y is -(CH2)2-, -(CH2)3-, -CH2CH(CH3)- or -CH2C(CH3)2-;R3 is hydrogen or a group selected from:-where R4 is H, C1-C4 alkyl, C3-C6 cycloalkyl, -COO(C1-C4 alkyl), -CH2COO(C1-C4 alkyl), aryl, -S02.aryl, or heteroaryl, and X is 0 or S;where R5 is 1-pyrrolidinyl, -NH2, -NH(C1-C4 alkyl), -N/C1-C4 alkyl)2, or -NH(CH2)2N(C1-C4 alkyl)2;where R6 is C1-C4 alkyl or aryl;where R7 is -CONH(C1-C4 alkyl) or -COO(C1-C4 alkyl);where R8 is -CN, -SO2(C1-C4 alkyl) or -SO2 aryl;(h) -CH2CO.R9 where R9 is -NH2, -NH(C1-C4 alkyl), -NH.aryl or C1-C4 alkoxy;(i) -SO2.R10 where R10 is -NH2, -N(C1-C4 alkyl)2 or C1-C4 alkyl; and(j) -CO.R" where R" is H, halomethyl, -COO(C1-C4 alkyl), -CH2O(C1-C4 alkyl), -CH2CO(C1-C4 alkyl), C1-C4 alkyl, C1-C4 alkoxy, aryl, heteroaryl, morpholino or 5-oxo-pyrrolidin-2-yl.The compounds have utility as anti-ischaemic and antihypertensive agents.</description><edition>4</edition><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1989</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19891031&amp;DB=EPODOC&amp;CC=YU&amp;NR=43659B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19891031&amp;DB=EPODOC&amp;CC=YU&amp;NR=43659B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>COMPBELL S.F</creatorcontrib><creatorcontrib>STUBBS J.K</creatorcontrib><creatorcontrib>CROSS P.E</creatorcontrib><title>PROCESS FOR MAKING DIHYDROPYRIDINE</title><description>1,4-Dihydropyridine derivatives of the formula:-and their pharmaceutically acceptable acid addition salts; whereR is aryl or heteroaryl;R1 and R2 are each independently C1-C4 alkyl or 2-methoxyethyl;Y is -(CH2)2-, -(CH2)3-, -CH2CH(CH3)- or -CH2C(CH3)2-;R3 is hydrogen or a group selected from:-where R4 is H, C1-C4 alkyl, C3-C6 cycloalkyl, -COO(C1-C4 alkyl), -CH2COO(C1-C4 alkyl), aryl, -S02.aryl, or heteroaryl, and X is 0 or S;where R5 is 1-pyrrolidinyl, -NH2, -NH(C1-C4 alkyl), -N/C1-C4 alkyl)2, or -NH(CH2)2N(C1-C4 alkyl)2;where R6 is C1-C4 alkyl or aryl;where R7 is -CONH(C1-C4 alkyl) or -COO(C1-C4 alkyl);where R8 is -CN, -SO2(C1-C4 alkyl) or -SO2 aryl;(h) -CH2CO.R9 where R9 is -NH2, -NH(C1-C4 alkyl), -NH.aryl or C1-C4 alkoxy;(i) -SO2.R10 where R10 is -NH2, -N(C1-C4 alkyl)2 or C1-C4 alkyl; and(j) -CO.R" where R" is H, halomethyl, -COO(C1-C4 alkyl), -CH2O(C1-C4 alkyl), -CH2CO(C1-C4 alkyl), C1-C4 alkyl, C1-C4 alkoxy, aryl, heteroaryl, morpholino or 5-oxo-pyrrolidin-2-yl.The compounds have utility as anti-ischaemic and antihypertensive agents.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1989</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFAKCPJ3dg0OVnDzD1LwdfT29HNXcPH0iHQJ8g-IDPJ08fRz5WFgTUvMKU7lhdLcDHJuriHOHrqpBfnxqcUFicmpeakl8ZGhJsZmppZOTsYEFQAAjsAhzQ</recordid><startdate>19891031</startdate><enddate>19891031</enddate><creator>COMPBELL S.F</creator><creator>STUBBS J.K</creator><creator>CROSS P.E</creator><scope>EVB</scope></search><sort><creationdate>19891031</creationdate><title>PROCESS FOR MAKING DIHYDROPYRIDINE</title><author>COMPBELL S.F ; STUBBS J.K ; CROSS P.E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_YU43659BB3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1989</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>COMPBELL S.F</creatorcontrib><creatorcontrib>STUBBS J.K</creatorcontrib><creatorcontrib>CROSS P.E</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>COMPBELL S.F</au><au>STUBBS J.K</au><au>CROSS P.E</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PROCESS FOR MAKING DIHYDROPYRIDINE</title><date>1989-10-31</date><risdate>1989</risdate><abstract>1,4-Dihydropyridine derivatives of the formula:-and their pharmaceutically acceptable acid addition salts; whereR is aryl or heteroaryl;R1 and R2 are each independently C1-C4 alkyl or 2-methoxyethyl;Y is -(CH2)2-, -(CH2)3-, -CH2CH(CH3)- or -CH2C(CH3)2-;R3 is hydrogen or a group selected from:-where R4 is H, C1-C4 alkyl, C3-C6 cycloalkyl, -COO(C1-C4 alkyl), -CH2COO(C1-C4 alkyl), aryl, -S02.aryl, or heteroaryl, and X is 0 or S;where R5 is 1-pyrrolidinyl, -NH2, -NH(C1-C4 alkyl), -N/C1-C4 alkyl)2, or -NH(CH2)2N(C1-C4 alkyl)2;where R6 is C1-C4 alkyl or aryl;where R7 is -CONH(C1-C4 alkyl) or -COO(C1-C4 alkyl);where R8 is -CN, -SO2(C1-C4 alkyl) or -SO2 aryl;(h) -CH2CO.R9 where R9 is -NH2, -NH(C1-C4 alkyl), -NH.aryl or C1-C4 alkoxy;(i) -SO2.R10 where R10 is -NH2, -N(C1-C4 alkyl)2 or C1-C4 alkyl; and(j) -CO.R" where R" is H, halomethyl, -COO(C1-C4 alkyl), -CH2O(C1-C4 alkyl), -CH2CO(C1-C4 alkyl), C1-C4 alkyl, C1-C4 alkoxy, aryl, heteroaryl, morpholino or 5-oxo-pyrrolidin-2-yl.The compounds have utility as anti-ischaemic and antihypertensive agents.</abstract><edition>4</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_YU43659BB
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title PROCESS FOR MAKING DIHYDROPYRIDINE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T00%3A35%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=COMPBELL%20S.F&rft.date=1989-10-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EYU43659BB%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true